NDC 51991-959
miglustat
Miglustat
miglustat is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Breckenridge Pharmaceutical, Inc.. The primary component is Miglustat.
| Product ID | 51991-959_88e64165-dd9a-4308-918d-4f91d643f802 |
| NDC | 51991-959 |
| Product Type | Human Prescription Drug |
| Proprietary Name | miglustat |
| Generic Name | Miglustat |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-03-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA209325 |
| Labeler Name | Breckenridge Pharmaceutical, Inc. |
| Substance Name | MIGLUSTAT |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Glucosylceramide Synthase Inhibitor [EPC], Glucosylceramide Synthase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |